Volume : 10, Issue : 04, April – 2023
Title:
12.BRAIN METASTASES: A REVIEW ARTICLE
Authors :
Ali Muntazir Naqvi, Anum Zehra, Syed Aqib Ali Zaidi ,Hina Khan, Arif Ali Chishti
Abstract :
Cerebral metastases or brain metastases (brain mets) is the most common malignant intracranial cancer among all brain tumors. Brain mets are the secondary tumors migrated from the distinct organs to brain i.e. lung, breast, melanoma and kidney. Cerebral tumors have higher mortality rate among all cancers with poor prognosis. Main steps of brain metastatic cascade are: epethelial-to-mesenchymal transition of primary tumor cells, crossing the blood brain barrier (BBB) and colonization of metastatic cells in the brain. BBB plays important role in both protecting the CNS and also providing the support to metastatic tumor cells for angiogenenesis and propagation. Diagnosis of brain mets is done with imaging techniques and biopsy. Different therapeutics strategies are used to treat the brain metastases patient including surgery or stereotactic radiosurgery, whole brain radiation and targeted molecular and immunotherapies. The present review article will update the understanding of the reader by providing a comprehensive information related to brain metastases, how it is different from primary brain tumor and how the tumor cells cross the blood brain barrier and form the colonies in brain. Further, the present review article will describe the current studies on the molecular factors found to be associated with brain metastasis. At the end of the review article the available diagnosis and treatment options will be discussed.
Key Words : Cancer, blood brain barrier, brain, tumor, metastasis.
Cite This Article:
Please cite this article in press Ali Muntazir Naqvi et al, Brain Metastases: A Review Article., Indo Am. J. P. Sci, 2023; 10 (04).
Number of Downloads : 10
References:
1. Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (2008 Sep 1) Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical research 25(9):2097-116.
2. Croce CM (2008 Jan 31) Oncogenes and cancer. New England journal of medicine 358(5):502-11.
3. Kanwal R, Gupta S (2012 Apr) Epigenetic modifications in cancer. Clinical genetics 81(4):303-11.
4. Hanahan D, Weinberg RA (2011 Mar 4) Hallmarks of cancer: the next generation. Cell 144(5):646-74.
5. Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, Klaske A, Hollema H, Boezen HM, van der Zee AG, Daemen T, Nijman HW (2009 Mar 1) Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunology, Immunotherapy 58(3):449.
6. Chiang AC, Massagué J (2008 Dec 25) Molecular basis of metastasis. New England Journal of Medicine 359(26):2814-23.
7. Nguyen DX, Bos PD, Massagué J (2009 Apr) Metastasis: from dissemination to organ-specific colonization. Nature Reviews Cancer 9(4):274-84.
8. Kall SL, Koblinski JE (2013) Genes that mediate metastasis organotropism. InMadame Curie Bioscience Database [Internet] Landes Bioscience.
9. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF (2010 Aug) Role of the metastasis‐promoting protein osteopontin in the tumour microenvironment. Journal of cellular and molecular medicine 14(8):2037-44.
10. Meleth S, Whitehead N, Evans TS, Lux L (2013) Technology assessment on genetic testing or molecular pathology testing of cancers with unknown primary site to determine origin.
11. Matrisian LM., Welch DR (2014 Jan 4) Invasion and Metastasis. In: Mendelsohn J, Howely PM, Israel MA, Gray JW, Thompson CB The Molecular Basis of Cancer E-Book. Elsevier Health Science.
12. KK K, Rajan MS, Hegde K, Koshy S, Shenoy A. A (2013 Oct 1) COMPREHENSIVE REVIEW ON BRAIN TUMOR. International Journal of Pharmaceutical, Chemical & Biological Sciences 3(4).
13. Wirsching HG, Weller M (2019) Basics of Brain Tumor Biology for Clinicians. InNeurorehabilitation in Neuro-Oncology 7-19. Springer, Cham.
14. Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016 Jun 1) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta neuropathologica 131(6):803-20.
15. Persaud-Sharma D, Burns J, Trangle J, Moulik S (2017 Sep) Disparities in brain cancer in the United States: a literature review of gliomas. Medical Sciences 5(3):16.
16. de Robles P, Fiest KM, Frolkis AD, Pringsheim T, Atta C, St. Germaine-Smith C, Day L, Lam D, Jette N (2015 Jun 1) The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro-oncology 17(6):776-83.
17. McNeill KA. Epidemiology of brain tumors. Neurologic clinics. 2016 Nov 1;34(4):981-98.
18. Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, Peters S, Arvold ND, Harsh GR, Steeg PS, Chang SD (2019 Jan 17) Brain metastases. Nature Reviews Disease Primers 5(1):1-26.
19. Fidler IJ (2015 Jul 1) The biology of brain metastasis: challenges for therapy. The Cancer Journal 21(4):284-93.
20. Langley RR, Fidler IJ (2013 Jan 1) The biology of brain metastasis. Clinical chemistry 59(1):180-9.
21. Bekaert L, Emery E, Levallet G, Lechapt-Zalcman E (2017 Jan 1) Histopathologic diagnosis of brain metastases: current trends in management and future considerations. Brain tumor pathology 34(1):8-19.
22. Bazille C, Rousseau A, Burel-Vandenbos F, Pierga JY (2015 Jan 27) Histological and molecular analysis of brain metastases. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 19(1):10-5.
23. Stelzer KJ (2013) Epidemiology and prognosis of brain metastases. Surgical neurology international 4(Suppl 4):S192.
24. Pekmezci M, Perry A (2013) Neuropathology of brain metastases. Surgical neurology international 4(Suppl 4):S245.
25. Navarro-Olvera JL, Arinez-Barahona E, Esqueda-Liquidano MA, Munoz-Cobos A (2017 Jan 1) Brain metastases: Literature review. Revista Médica del Hospital General de México 80(1):60-6.
26. Caroli M, Di Cristofori A, Lucarella F, Raneri FA, Portaluri F, Gaini SM (2011) Surgical brain metastases: management and outcome related to prognostic indexes: a critical review of a ten-year series. ISRN surgery 2011.
27. Furet E, El Bouchtaoui M, Feugeas JP, Miquel C, Leboeuf C, Beytout C, Bertheau P, Le Rhun E, Bonneterre J, Janin A, Bousquet G (2017 Jun 6) Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes. Oncotarget 8(23):37332.
28. Jesús RM, Iñigo VA, Luis BL, Chávez H, Allan PM, Liliana NR, Roque ER (2019) Diagnosis and management of brain metastases: an updated review from a radiation oncology perspective.
29. Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler F, Wick W (2012 Feb 1) Brain metastases: pathobiology and emerging targeted therapies. Acta neuropathologica 123(2):205-22.
30. Nayak L, Lee EQ, Wen PY (2012 Feb 1) Epidemiology of brain metastases. Current oncology reports 14(1):48-54.
31. Quail DF, Joyce JA (2017 Mar 13) The microenvironmental landscape of brain tumors. Cancer cell 31(3):326-41.
32. Phillips C, Jeffree R, Khasraw M (2017 Feb 1) Management of breast cancer brain metastases: a practical review. The breast 31:90-8.
33. Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G (2011 Jan 1) Epidemiology of metastatic brain tumors. Neurosurgery Clinics 22(1):1-6.
34. Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018 Jan 1) Brain metastases: epidemiology. InHandbook of clinical neurology Vol. 149, pp. 27-42. Elsevier.
35. Hanibuchi M, Kim SJ, Fidler IJ, Nishioka Y (2014) The molecular biology of lung cancer brain metastasis: an overview of current comprehensions and future perspectives. The Journal of Medical Investigation 61(3.4):241-53.
36. Liao L, Ji X, Ge M, Zhan Q, Huang R, Liang X, Zhou X (2018 Sep) Characterization of genetic alterations in brain metastases from non‐small cell lung cancer. FEBS open bio 8(9):1544-52.
37. Rostami R, Mittal S, Rostami P, Tavassoli F, Jabbari B (2016 May 1) Brain metastasis in breast cancer: a comprehensive literature review. Journal of neuro-oncology 127(3):407-14.
38. Leone JP, Leone BA (2015 Dec) Breast cancer brain metastases: the last frontier. Experimental hematology & oncology 4(1):1-0.
39. Daphu I, Horn S, Stieber D, Varughese JK, Spriet E, Dale HA, Skaftnesmo KO, Bjerkvig R, Thorsen F (2014 May) In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways. International journal of molecular sciences 15(5):8773-94.
40. Heitzer E, Groenewoud A, Meditz K, Lohberger B, Liegl-Atzwanger B, Prokesch A, Kashofer K, Behrens D, Haybaeck J, Kolb-Lenz D, Koefeler H (2019 Mar 11) Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization. Scientific reports 9(1):1-3.
41. Tandel GS, Biswas M, Kakde OG, Tiwari A, Suri HS, Turk M, Laird JR, Asare CK, Ankrah AA, Khanna NN, Madhusudhan BK (2019 Jan) A review on a deep learning perspective in brain cancer classification. Cancers 11(1):111.
42. Beasley KD, Toms SA (2011 Jan 1) The molecular pathobiology of metastasis to the brain: a review. Neurosurgery Clinics 22(1):7-14.
43. Berghoff AS, Rajky O, Winkler F, Bartsch R, Furtner J, Hainfellner JA, Goodman SL, Weller M, Schittenhelm J, Preusser M (2013 Dec 1) Invasion patterns in brain metastases of solid cancers. Neuro-oncology 15(12):1664-72.
44. Blecharz KG, Colla R, Rohde V, Vajkoczy P (2015 Oct) Control of the blood–brain barrier function in cancer cell metastasis. Biology of the Cell 107(10):342-71.
45. Daphu I, Sundstrøm T, Horn S, Huszthy PC, Niclou SP, Sakariassen PØ, Immervoll H, Miletic H, Bjerkvig R, Thorsen F (2013 Jun 1) In vivo animal models for studying brain metastasis: value and limitations. Clinical & experimental metastasis 30(5):695-710.
46. Lopes MB (2018 Jan 1) Metastatic diseases of the central nervous system–neuropathologic aspects. InHandbook of Clinical Neurology Vol. 149, pp. 67-73. Elsevier.
47. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018 Nov) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 68(6):394-424.
48. Ramakrishna R, Rostomily R (2013) Seed, soil, and beyond: The basic biology of brain metastasis. Surgical neurology international 4(Suppl 4):S256.
49. Izraely S, Sagi‐Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik‐Chor M, Nahmias C, Couraud PO, Ateh E, Bryant JL, Hoon DS (2012 Sep 1) The metastatic microenvironment: brain‐residing melanoma metastasis and dormant micrometastasis. International journal of cancer 131(5):1071-82.
50. Brodbelt A, Zakaria R (2019 Sep) Intracranial metastases. Oxford Textbook of Neurological Surgery 26:107.
51. Weidle UH, Birzele F, Kollmorgen G, Rueger R (2016 Jul 1) Dissection of the process of brain metastasis reveals targets and mechanisms for molecular-based intervention. Cancer Genomics-Proteomics 13(4):245-58.
52. Zhang C, Yu D (2016 Dec 1) Advances in decoding breast cancer brain metastasis. Cancer and Metastasis Reviews 35(4):677-84.
53. Jesús RM, Iñigo VA, Luis BL, Chávez H, Allan PM, Liliana NR, Roque ER (2019) Diagnosis and management of brain metastases: an updated review from a radiation oncology perspective.
54. Hafeez U, Cher LM (2019 May) Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects. Neuro-Oncology Advances 1(1):vdz013.
55. Jeevan DS, Cooper JB, Braun A, Murali RA, Jhanwar-Uniyal M (2016 Feb 1) Molecular pathways mediating metastases to the brain via epithelial-to-mesenchymal transition: genes, proteins, and functional analysis. Anticancer research 36(2):523-32.
56. Rahmathulla G, Toms SA, Weil RJ (2012 Jan 1) The molecular biology of brain metastasis. Journal of oncology.
57. Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK (2011 Jun) The biology of brain metastases—translation to new therapies. Nature reviews Clinical oncology 8(6):344.
58. Cooper JB, Ronecker JS, Tobias ME, Mohan AL, Hillard V, Murali R, Gandhi CD, Schmidt MH, Jhanwar-Uniyal M (2018 Apr 1) Molecular sequence of events and signaling pathways in cerebral metastases. Anticancer research 38(4):1859-77.
59. Svokos KA, Salhia B, Toms SA (2014 Jun) Molecular biology of brain metastasis. International journal of molecular sciences 15(6):9519-30.
60. Han CH, Brastianos PK (2017 Sep 25) Genetic characterization of brain metastases in the era of targeted therapy. Frontiers in Oncology 7:230.
61. Wingrove E, Liu ZZ, Patel KD, Arnal-Estapé A, Cai WL, Melnick MA, Politi K, Monteiro C, Zhu L, Valiente M, Kluger HM (2019 Apr 23) Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis. Cell reports 27(4):1277-92.
62. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massagué J (2009 Jun) Genes that mediate breast cancer metastasis to the brain. Nature 459(7249):1005-9.
63. Jia W, Martin TA, Zhang G, Jiang WG (2013 Jun 1) Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis. Anticancer research 33(6):2353-9.
64. Maher EA, Mietz J, Arteaga CL, DePinho RA, Mohla S (2009) Brain metastasis: opportunities in basic and translational research.
65. Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA (2013 Jan) Role of the blood-brain barrier in the formation of brain metastases. International journal of molecular sciences 14(1):1383-411.
66. Fidler IJ (2011 Apr 1) The role of the organ microenvironment in brain metastasis. InSeminars in cancer biology Vol. 21, No. 2, pp. 107-112. Academic Press.
67. Zhang C, Yu D (2011 Feb) Microenvironment determinants of brain metastasis. Cell & bioscience 1(1):1-6.
68. Cacho-Díaz B, García-Botello DR, Wegman-Ostrosky T, Reyes-Soto G, Ortiz-Sánchez E, Herrera-Montalvo LA (2020) Tumor microenvironment differences between primary tumor and brain metastases. Journal of Translational Medicine 18(1):1.
69. Lowery FJ, Yu D (2017 Jan 1) Brain metastasis: unique challenges and open opportunities. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1867(1):49-57.
70. Krizbai I, Fazakas C, Nagyoszi P, Farkas A, Hasko J, Molnar J, Vegh G, Varo G, Wilhelm I (2011 Sep) The role of the blood-brain barrier in the formation of brain metastases. Pharmacological Reports 63(5):1275.
71. Connell JJ, Chatain G, Cornelissen B, Vallis KA, Hamilton A, Seymour L, Anthony DC, Sibson NR (2013 Nov 1) Selective permeabilization of the blood–brain barrier at sites of metastasis. Journal of the national cancer institute 105(21):1634-43.
72. Arshad F, Wang L, Sy C, Avraham S, Avraham HK (2010 Dec 29) Blood-brain barrier integrity and breast cancer metastasis to the brain. Pathology research international 2011:920509.
73. Serlin Y, Shelef I, Knyazer B, Friedman A (2015 Feb 1) Anatomy and physiology of the blood–brain barrier. InSeminars in cell & developmental biology Vol. 38, pp. 2-6. Academic Press.
74. Arvanitis CD, Ferraro GB, Jain RK (2019 Oct 10) The blood–brain barrier and blood–tumour barrier in brain tumours and metastases. Nature Reviews Cancer 1-6.
75. Winkler F (2015 Nov 1) The brain metastatic niche. Journal of Molecular Medicine 93(11):1213-20.
76. Singh M, Manoranjan B, Mahendram S, McFarlane N, Venugopal C, Singh SK (2014 May) Brain metastasis-initiating cells: survival of the fittest. International journal of molecular sciences 15(5):9117-33.
77. Levin VA, Tonge PJ, Gallo JM, Birtwistle MR, Dar AC, Iavarone A, Paddison PJ, Heffron TP, Elmquist WF, Lachowicz JE, Johnson TW (2015 Nov 1) CNS anticancer drug discovery and development conference white paper. Neuro-oncology 17(suppl_6):vi1-26.
78. Sprowls SA, Arsiwala TA, Bumgarner JR, Shah N, Lateef SS, Kielkowski BN, Lockman PR (2019 Aug 1) Improving CNS Delivery to Brain Metastases by Blood–Tumor Barrier Disruption. Trends in cancer 5(8):495-505.
79. Winkler F (2014) The brain microenvironment: friend or foe for metastatic tumor cells?.
80. You H, Baluszek S, Kaminska B (2019) Immune microenvironment of brain metastases-are microglia little helpers?. Frontiers in immunology 10:1941.
81. Lu-Emerson C, Eichler AF (2012 Apr 1) Brain metastases. CONTINUUM: Lifelong Learning in Neurology 18(2):295-311.
82. Lorger M, Felding-Habermann B (2010 Jun 1) Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. The American journal of pathology 176(6):2958-71.
83. Becher MW, Abel TW, Thompson RC, Weaver KD, Davis LE (2006 Oct 1) Immunohistochemical analysis of metastatic neoplasms of the central nervous system. Journal of Neuropathology & Experimental Neurology 65(10):935-44.
84. Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A (2019 Aug) Current and future trends on diagnosis and prognosis of glioblastoma: From molecular biology to proteomics. Cells 8(8):863.
85. Kienast Y, Von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, Winkler F (2010 Jan) Real-time imaging reveals the single steps of brain metastasis formation. Nature medicine 16(1):116-22.
86. Mills SJ, Thompson G, Jackson A (2012) Advanced magnetic resonance imaging biomarkers of cerebral metastases. Cancer Imaging 12(1):245.
87. Fink KR, Fink JR (2013) Imaging of brain metastases. Surgical neurology international 4(Suppl 4):S209.
88. Anzalone N, Essig M, Lee SK, Dörfler A, Ganslandt O, Combs SE, Picozzi P (2013 May 1) Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery. Neurosurgery 72(5):691-701.
89. Barciszewska AM (2018 Oct 31) Global DNA demethylation as an epigenetic marker of human brain metastases. Bioscience reports 38(5).
90. Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T (2014 Apr) Current approaches to the treatment of metastatic brain tumours. Nature reviews Clinical oncology 11(4):203.
91. Kyritsis AP, Markoula S, Levin VA (2012 Jan 1) A systematic approach to the management of patients with brain metastases of known or unknown primary site. Cancer chemotherapy and pharmacology 69(1):1-3.
92. Hamilton A, Sibson NR (2013 Mar 1) Role of the systemic immune system in brain metastasis. Molecular and Cellular Neuroscience 53:42-51.
93. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Hassel MB (2011 Jan 10) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. Journal of Clinical Oncology 29(2):134.
94. Ren D, Zhu X, Kong R, Zhao Z, Sheng J, Wang J, Xu X, Liu J, Cui K, Zhang XH, Zhao H (2018 Apr 15) Targeting brain-adaptive cancer stem cells prohibits brain metastatic colonization of triple-negative breast cancer. Cancer research 78(8):2052-64.
95. Lim M, Puttick S, Houston ZH, Thurecht KJ, Kalita-de Croft P, Mahler S, Rose SE, Jeffree RL, Mazzieri R, Dolcetti R, Lakhani SR (2019 Jan) Innovative therapeutic strategies for effective treatment of brain metastases. International journal of molecular sciences 20(6):1280.
96. Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM (2011 Mar 15) Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clinical cancer research 17(6):1603-15